Company	Share, %
MedAvail Holdings, Inc.	42.88
ADC Therapeutics SA	18.57
Fate Therapeutics	13.27
Shattuck Labs, Inc.	11.84
Zymeworks Inc.	9.19
IGM Biosciences, Inc.	8.93
Epizyme, Inc.	8.33
Scholar Rock Holding Corporation	8.22
Immunome	8.15
Lava Therapeutics B.V.	7.89
REGENXBIO	7.67
Atara Biotherapeutics	7.63
Absci Corporation	7.3
ALX Oncology Holdings Inc.	7.3
Annexon, Inc.	7.02
ImmunoGen	6.57
Replimune Group, Inc.	6.3
Neoleukin Therapeutics, Inc.	6.2
Krystal Biotech, Inc.	6.08
Gritstone Oncology, Inc.	5.99
Deciphera Pharmaceuticals, Inc.	5.94
Stoke Therapeutics, Inc.	5.67
Amicus Therapeutics, Inc.	5.02
Repare Therapeutics Inc.	4.75
Pliant Therapeutics, Inc.	4.48
Allakos Inc.	4.18
Achilles Therapeutics plc	3.91
Entrada Therapeutics, Inc.	3.82
RayzeBio, Inc. Common Stock	3.1
IVERIC bio, Inc.	3.05
Stereotaxis, Inc.	1.84
TCR2 Therapeutics Inc.	1.68
AlloVir, Inc.	1.66
Zymergen Inc.	1.49
Atreca, Inc.	1.35
Invivyd, Inc.	1.31
Eidos Therapeutics, Inc.	1.21
HOOKIPA Pharma Inc.	1.1
Prime Medicine, Inc.	1.1
Science 37 Holdings, Inc.	0.83
Invitae Corporation	0.8
Alpha Teknova, Inc.	0.39
Augmedix, Inc.	0